Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction

American Journal of Cardiology

Volumn 82, Issue 1, 1998, Pages 26-31

  Fath Ordoubadi, Farzin ^b   Pagano, Domenico ^b   Marinho, Norma V S ^b   Keogh, Bruce E ^b   Bonser, Robert S ^b   Camici, Paolo G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE WALL MOTION; HUMAN; MALE; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; TREATMENT INDICATION;

ADULT; AGED; ANIMALS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE VENTRICULOGRAPHY; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032126246     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00241-0     Document Type: Article

References (30)

1. Beller G.A., Ragosta M., Watson D.D., Gimple L.W. Myocardial thallium-201 scintigraphy for assessment of viability in patients with severe left ventricular dysfunction. Am J Cardiol. 70:1992;18E-22E.
2. Dilsizian V., Arrighi J.A., Diodati J.G., Quyyumi A.A., Alavi K., Bacharach S.L., Marin-Neto J.A., Katsiyiannis P.T., Bonow R.O. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Circulation. 1989;578-587.
3. Galli M., Marcassa C. Thallium-201 redistribution after early reinjection in patients with severe stress perfusion defects and ventricular dysfunction. Am Heart J. 128:1994;41-52.
4. Afridi I., Kleiman N.S., Raizner A.E., Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 91:1995;663-670.
5. La Canna G., Alfieri O., Giubbini R., Gargano M., Ferrari R., Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 23:1994;617-626.
6. Pierard L.A., De Landsheere C.M., Berthe C., Rigo P., Kulbertus H.E. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography . J Am Coll Cardiol. 15:1990;1021-1031.
7. Tillisch J., Brunken R., Marshall R., Schwaiger M., Child J.S., Marshall R., Mandelkern M., Phelps M., Schelbert H.R. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions evidence for persistence of viable tissue in some infarct regions by positron emission tomography . Circulation. 73:1986;951-963.
8. Tamaki N., Yoshiharu Y., Yamashita K., Saji H., Magata Y., Senda M., Konishi Y., Hirata K., Ban T., Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 64:1989;860-865.
9. Nienaber C.A., Brunken R.C., Sherman C.T., Yeatman L.A., Gambhir S.S., Krivokapich J., Demer L.L., Ratib O.M., Child J.S., Phelps M.E., Schelbert H.R. Metabolic and functional recovery of ischaemia human myocardium after coronary angioplasty. J Am Coll Cardiol. 18:1991;966-978.
10. Eitzman D., Al-Aouar Z., Kanter H.L., vom Dahl J., Kirsh M., Deeb G.M., Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 20:1992;559-565.
11. Gropler R.J., Geltman E.M., Sampathkumaran K., Perez J.E., Moerlein S.M., Sobel B.E., Bergmann S.R., Siegel B.A. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol. 20:1992;569-577.
12. Carrel T., Jenni R., Haulbold-Reuter S., von Schulthess G., Pasic M., Turina M. Improvement of severely reduced left ventricular function after surgical revascularization in patients with pre-operative myocardial infarction. Eur J Cardiothorac Surg. 6:1992;479-484.
13. Marwick T.H., MacIntyre W.J., Lafont A., Nemec J.J., Salcedo E.E. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation. 85:1992;1347-1353.
14. Vanoverschelde J.-L.J., Wijns W., Depre C., Essamri B., Heyndrickx G.R., Borgers M., Bol A., Melin J.A. Mechanisms of chronic regional postischaemic dysfunction in humans new insights from the study of noninfarcted collateral-dependent myocardium . Circulation. 87:1993;1513-1523.
15. vom Dahl J., Eitzman D.T., Al-Aouar Z.R., Lee Kanter H., Hicks R.J., Michael Deeb G., Kirsh M.M., Schwaiger M. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 90:1994;2356-2366.
16. Lucignani G., Paolini G., Landoni C., Zuccari M., Paganelli G., Galli L., Di-Credico G., Vanoli G., Rossetti C., Mariani M.A. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrite single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med. 19:1992;874-881.
17. Knuuti M.J., Nuutila P., Ruotsalainen U., Saraste M., Harkonen R., Ahonen A., Teras M., Haaparanta M., Wegelius U., Haapanen A., Hartiala J., Voipio-Pulkki L.M. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilisation during positron emission tomography. J Nucl Med. 33:1992;1255-1262.
18. Tillisch J., Brunken R., Marshall R., Schwaiger M., Mandelkern M., Phelps M.E., Schelbert H.R. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
19. Marinho N.V.S., Keogh B.E., Costa D.C., Lammerstma A.A., Ell P.J., Camici P.G. Pathophysiology of chronic left ventricular dysfunction new insights from the measurement of absolute myocardial blood flow and glucose utilization . Circulation. 93:1996;737-744.
20. Gerber B.L., Vanoverschelde J.L.-J., Bol A., Michel C., Labar D., Wijns W., Melin J.A. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction implications for the pathophysiology of chronic myocardial hibernation . Circulation. 94:1996;651-659.
21. vom Dahl J., Altehoefer C., Sheehan F.H., Buechin P., Uebis R., Messmer B.J., Buell U., Hanrath P. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol. 28:1996;948-958.
22. De Fronzo R.A., Jordan D.T., Reubin A. Glucose clamp technique a method for quantifying insulin secretion and resistance . Am J Physiol. 237:1979;E214-E223.
23. Di Carli M.F., Asgarzadie F., Schelbert H.R., Brunken R.C., Laks H., Phelps M.E., Maddahi J. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 92:1995;3436-3444.
24. Maddahi J., Schelbert H., Brunken R., Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary disease and left ventricular dysfunction. J Nucl Med. 35:1994;707-715.
25. Choi Y., Brunken R.C., Hawkins R.A., Huang S.C., Buxton D.B., Hoh C.K., Phelps M.E., Schelbert H.R. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med. 20:1993;308-318.
26. Gropler R.J., Siegel B.A., Lee K.J., Moerlein S.M., Perry D.J., Bergmann S.R., Geltman E.M. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med. 31:1990;1749-1756.
27. Tamaki N., Yonekura Y., Konishi J. Myocardial FDG PET studies with the fasting, oral glucose-loading or insulin clamp methods. J Nucl Med. 33:1992;1263-1268.
28. Knuuti M.J., Nuutila P., Ruotsalainen U., Saraste M., Harkonen R., Ahonen A., Teras M., Haaparanta M., Wegelius U., Haapanen A., Hartiala J., Voipio-Pulkki L.M. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilisation during positron emission tomography. J Nucl Med. 33:1992;1255-1262.
29. Braunwald E., Kloner R.A. The stunned myocardium prolonged post-ischaemia ventricular dysfunction . Circulation. 66:1983;1146-1149.
30. Matsuzaki M., Gallagher K.P., Kemper W.S., White F., Ross J. Jr. Sustained regional dysfunction produced by prolonged coronary stenosis gradual recovery after reperfusion . Circulation. 68:1983;170-182.